Atlas Trials

Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Clinical trial NCT01716364 · UNKNOWN

Trial details

NCT number
NCT01716364
Sponsor
Peter MacCallum Cancer Centre, Australia
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple MyelomaAcute Myeloid LeukaemiaMyelodysplastic Syndrome
Start date
2010-01-01
Primary completion
2013-12-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.